Magnetic proton therapeutic instrument, the first domestic ultra-high-speed centrifuge, the panoramic ecosystem for the use of hazardous chemicals, and the first global aviation temperature control industry ecological platform … At the 5th China International Import Expo (referred to as "China International Import Expo(CIIE)"), Yingkang, a big health ecological brand of Haier’s Internet of Things, made its debut with a number of cutting-edge scientific and technological innovations.

　　From the single display of scientific and technological innovation products to the self-developed innovation achievements reaching the international leading level, to the whole scene of ecological solutions landing and going to overseas markets, looking back on the three years of participating in China International Import Expo(CIIE), Gong Wenwen, the chief strategy officer of Yingkang Life, lamented the tremendous changes it brought. "China International Import Expo(CIIE) has built a bridge for global trade opening and circulation, bringing a global vision to China enterprises, not only displaying innovation achievements, but also building a platform for China enterprises to explore overseas markets and accelerating business integration and technological innovation."

　　From "0" to "1" to "n" Haier independently researched and developed to open up a new situation of industrial development.

　　In recent years, with the implementation of relevant policies and industrial planning, the medical device industry has continuously made new innovations, and medical device manufacturers have paid more and more attention to independent research and development and innovation to pry open a new situation of industrial development. Yingkang, a subsidiary of Haier, is a leader in this period.

　　The key to medical innovation lies in scientific and technological innovation. Scientific and technological innovation is the foundation of enterprise’s survival and the source of development. Only through continuous innovation and finding more new opportunities and new directions can we achieve sustainable and high-quality development.

　　The "Xiangyun" ultra-high-speed centrifuge, which is being exhibited for the first time in the world at the 5th China International Import Expo(CIIE), is one of the scientific and technological innovations independently developed by Haier Biomedical under Yingkang Lifetime. This is also the first time that China has broken through the technical bottleneck of ultra-high-speed centrifuges and has completely independent intellectual property rights.

　　As an essential instrument for the scene of sample separation in the laboratory, centrifuges are mainly used for the separation and purification of biological macromolecules, organelles and viruses, and the determination of relative molecular weight, etc. The greater the rotating speed, the finer the sample separation. The "Xiangyun" ultra-high-speed centrifuge independently developed by Haier Biomedical has a rotating speed of 50000rpm and a maximum centrifugal force of 135557xg, which can separate specific membrane proteins of tumor cells, identify tumor cells, provide a basis for the research and development of tumor-targeted drugs, and provide equipment support for the research and development of cutting-edge technologies in life sciences, medical innovation and other fields.

　　In the planning perspective of Yingkang’s life, scientific and technological innovation is not limited to the breakthrough in a single direction, but runs through the whole process of the medical and health industry chain.

　　Breakthrough begins with every obstacle on the road to localization. In the field of bio-safety, as an important part of the medical and health industrial chain, aviation temperature control is regarded as an international "life transport line". But for a long time, in the field of aviation temperature control logistics, China enterprises have always lacked industry "breakers".

　　Meng Zhigang, general manager of the aviation temperature control industry of Haier Biomedical Co., Ltd., a subsidiary of Yingkang Lifetime, introduced that Haier Biomedical has surmounted the three mountains of technical barriers, no standard to follow and supply blockade in the absence of domestic experience, and overcome the technical problems of active aviation temperature control technology in terms of temperature uniformity, battery life and energy consumption, realizing accurate and uniform control of the internal temperature of the box and fully automatic real-time recording, and innovating the first active aviation temperature control container in the industry.

　　"Compared with similar foreign products, Haier Biomedical’s self-developed active aviation temperature-controlled container not only prolongs the battery life by nearly 50%, but also makes it more convenient for users to use; It has also reduced power consumption by 20%, which is more green and energy-saving. " According to the person in charge, it took Haier Biomedical only one year to complete the research, development and listing of the first product, and pushed the high-end aviation temperature control scheme in China to the world. "This is all due to Haier’s complete scientific and technological innovation system."

　　"10+N" open innovation ecosystem promotes the rapid transformation of innovation achievements

　　"Two-way integration" between industrial chain and innovation chain is the necessary way to realize the commercial value of scientific and technological innovation and the high added value of industrial chain. This is not only an important starting point to promote the conversion of old and new kinetic energy, but also a necessary way to achieve high-quality growth.

　　At present, Yingkang has formed a development model of "technological independent innovation+scene fusion innovation" all his life, which is based on tackling core technologies and driven by user needs, accelerating the iteration from technology to patent to standard, and promoting the breakthrough and innovation from "0" to "1" in the industrial field.

　　Take ——INFINI head gamma knife, a radiotherapy "sharp blade" independently developed and produced by Yingkang for example, its radiotherapy accuracy has reached nearly three times of the international standard, and it has successively obtained several authoritative certifications such as CFDA certification in China, FDA certification in the United States and SS&D certification. While ranking first in installed capacity in China, Yingkang is also the only China brand that exports gamma knives to developed countries and "Belt and Road" countries. In July of this year, this scientific and technological achievement also ushered in a rapid transformation. Yingkang Yisheng Medical Device Digital Wisdom Ecological Park officially signed a contract with Qingdao High-tech Zone, planning to integrate a large-scale medical equipment production base, a high-end medical equipment research institute and a shared laboratory, and at the same time build a CDMO medical device industry ecology.

　　According to statistics, in the past 10 years, Haier has created more than 170 original scientific and technological innovations that have a significant impact on the industry, and all the innovations have been quickly transformed into the industrial chain.

　　"Where is the user, where is the research and development." In Haier’s view, each R&D center is not a walled garden, but should build a local innovation ecosystem and cooperate with the global R&D platform. Taking R&D center and innovation center as nodes, Haier has connected various innovation platforms, forming a global contact network, which can link more than 1 million first-class technical resources. This is the idea clarified by Haier’s "10+N" open innovation ecosystem.

　　Haier’s "10+N" open innovation ecosystem, that is, in the top 10 R&D centers around the world, N innovation centers, innovation networks and an expert community of innovation partners with more than 10,000 people are connected in parallel at any time according to users’ pain points, with a total of 71 research institutes, 259 design centers and more than 1,000 laboratories, which can be said to condense global resources to promote uninterrupted innovation.

　　With the blessing of policies and the acceleration of independent innovation of domestic equipment, Yingkang will continue to be user-centered and market-oriented, increase investment in research and development of medical devices, accelerate the development of deep integration of Industry-University-Research, and look forward to working together with first-class partners at home and abroad to continuously open up new tracks for economic development and promote the high-quality development of the medical device industry.

　　From cross-border "going out to sea" to global layout, scientific and technological innovation accelerates the globalization of national brands

　　With the development of independent innovation with China characteristics, more and more national brand enterprises have gone from cross-border "going out to sea" to seeking global distribution.

　　"Take root in China and look at the world." Gong Wenwen said that Yingkang has been deeply involved in the three major industries of biotechnology, medical devices and medical services all his life. The industrial chains of two listed companies, Haier Bio and Yingkang Life, have been aggregated and coordinated, and the global layout is also advancing.

　　For example, Yingkang Life has realized the independent export of large-scale radiotherapy equipment. As mentioned above, the head gamma knife has first landed in the United States, Europe, Latin America and Asia with its unique technical advantages and excellent clinical effects. Haier Bio is actively promoting the overseas replication of the scenario model and further promoting the layout of "network+localization". At present, there are more than 700 overseas distribution networks, and the localization response ability has been continuously improved in Europe, America, Southeast Asia and other regions, and the multi-category comprehensive scheme including ultra-low temperature storage products has been continuously upgraded to cover liquid nitrogen, biosafety, biological culture and other series, which has been applied in more than 130 countries and regions around the world.

　　It is understood that at the beginning of 2022, Haier Group established a Science and Technology Committee, which will implement core scientific and technological research in five common key technical directions: green double carbon, security privacy and compliance, chips and operating systems in professional fields, AIoT/ perception and interaction, and data productivity, and break through core technical problems in industries such as smart brain, smart home operating system, industrial intelligent BaaS engine, and sophisticated radiotherapy system. Support the high-quality development of business with original, independent and controllable differentiated technologies, products and scenarios, improve and upgrade the "four-level" R&D system, and promote the continuous iteration of technological innovation, global coordination of innovation capabilities and continuous upgrading of innovation systems.

　　Incorporating into the global layout under Haier’s scientific and technological innovation, Yingkang Lifelong said that it will increase international exchanges and cooperation, explore new modes of cooperating with Industry-University-Research at home and abroad, build a global smart supply chain system, continuously improve the international and efficient market service level, create value together with partners with an open attitude, and inject new momentum into the development of the big health industry.

　　(Source: New Vision)